Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment BusinessWire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on JNJ
    Johnson & Johnson to Participate in the BofA Securities Health Care Conference
    4:30p ET April 2 '24 BusinessWire

    Johnson & Johnson (NYSE: JNJ) will participate in the BofA Securities Health Care Conference on Tuesday, May 14th, at the Encore Hotel, Las Vegas, Nevada. John Reed, Executive Vice President, Innovative Medicine, R&D, will represent the Company in a session scheduled at 4:40 pm (Eastern Time).

    This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

    The audio webcast replay will be available approximately 48-hrs after the webcast.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240402572248/en/

    SOURCE: Johnson & Johnson

    <img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240402572248r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />

    Media contact:
    media-relations@its.jnj.com
    
    
    Investor contact:
    investor-relations@its.jnj.com
    

    COMTEX_450241861/1006/2024-04-02T16:30:06

    Kenvue Announces Pricing of Secondary Offering
    7:13p ET May 14 '24 BusinessWire
    Kenvue Announces Launch of Secondary Offering
    6:46a ET May 13 '24 BusinessWire
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:16p ET May 9 '24 PR Newswire Europe
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:15p ET May 9 '24 PR Newswire
    Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Glo...
    4:30p ET May 8 '24 BusinessWire
    Shockwave Medical Reports First Quarter 2024 Financial Results
    4:05p ET May 6 '24 GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:22p ET May 6 '24 GlobeNewswire
    Johnson & Johnson to Participate in the 2024 RBC Capital Markets Glob...
    6:06p ET April 8 '24 BusinessWire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:48p ET April 8 '24 GlobeNewswire
    CARVYKTI(R) is the First and Only BCMA-Targeted Treatment Approved by...
    11:22p ET April 5 '24 PR Newswire

    Market data provided by News provided by